{
    "clinical_study": {
        "@rank": "40010", 
        "arm_group": [
            {
                "arm_group_label": "<40 years", 
                "description": "subjects aged less than 40 years"
            }, 
            {
                "arm_group_label": "40-60 years", 
                "description": "subjects aged 40-60years"
            }, 
            {
                "arm_group_label": "> 60 years", 
                "description": "subjects aged greater than 60 years"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to measure the level of AlloMax\u2122 incorporation (cellular\n      infiltration, collagen production, and neovascularization) in human breast reconstruction.\n      The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast\n      capsule at the 3-4 month time point."
        }, 
        "brief_title": "Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12", 
        "completion_date": {
            "#text": "November 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM\n             implants and agree to participate will be included in this study.\n\n        Exclusion Criteria:\n\n          -  Patients who do not agree to be included in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients (18 - 70 yrs) scheduled for immediate two stage breast reconstruction with\n        AlloMaxTM are potential subjects for this study"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679223", 
            "org_study_id": "081512"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast reconstruction", 
            "Hydroxyproline concentration", 
            "neoangiogenesis", 
            "collagen deposition"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "contact": {
                "email": "smounts@medicine.nevada.edu", 
                "last_name": "Sherree Mounts, LPN", 
                "phone": "702-671-5117"
            }, 
            "facility": {
                "address": {
                    "city": "Las Vegas", 
                    "country": "United States", 
                    "state": "Nevada", 
                    "zip": "89102-2227"
                }, 
                "name": "University of Nevada School of Medicine"
            }, 
            "investigator": [
                {
                    "last_name": "Kayvan Taghipour-Khiabani, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "William A Zamboni, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Richard C Baynosa, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12", 
        "overall_contact": {
            "email": "kkhiabani@medicine.nevada.edu", 
            "last_name": "Kayvan Taghipour-Khiabani, M.D.", 
            "phone": "702-671-2267"
        }, 
        "overall_contact_backup": {
            "email": "lstephenson@medicine.nevada.edu", 
            "last_name": "Linda L Stephenson, BS MT(ASCP)", 
            "phone": "702-895-3315"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Nevada School of Medicine", 
                "last_name": "Kayvan Taghipour-Khiabani, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Nevada School of Medicine", 
                "last_name": "William A Zamboni, M.D.", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Hydroxyproline will be measured in the AlloMaxTM and adjacent capsule.", 
                "measure": "Hydroxyproline Concentration", 
                "safety_issue": "No", 
                "time_frame": "3-4 months"
            }, 
            {
                "description": "Measure new blood vessels in AlloMaxTM and adjacent capsule", 
                "measure": "Neoangiogenesis", 
                "safety_issue": "No", 
                "time_frame": "3-4 months"
            }, 
            {
                "description": "Measure collagen I and III in AlloMaxTM and adjacent capsule", 
                "measure": "Collagen I and III", 
                "safety_issue": "No", 
                "time_frame": "3-4 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679223"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Nevada, Las Vegas", 
            "investigator_full_name": "Kayvan Taghipour-Khiabani, M.D.", 
            "investigator_title": "Tenured Associate Professor, Head of Hand and Microsurgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Nevada, Las Vegas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Nevada, Las Vegas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}